Psychological aspects of diabetes mellitus

Child and Adolescent Psychiatric Clinics of North America

Volumn 12, Issue 3, 2003, Pages 439-458

  Szydlo, David ^a,b   Van Wattum, Pieter Joost ^a   Woolston, Joseph ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CENTRAL STIMULANT AGENT; CITALOPRAM; CLONIDINE; CLOZAPINE; FLUOXETINE; GUANFACINE; LAMOTRIGINE; LITHIUM; METFORMIN; METHYLPHENIDATE; NEUROLEPTIC AGENT; OLANZAPINE; OSMOTIC DIURETIC AGENT; PAROXETINE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; SIBUTRAMINE; TETRAHYDROLIPSTATIN; TOPIRAMATE; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE; ZIPRASIDONE;

ADAPTATION; ADOLESCENT; ANXIETY DISORDER; APPETITE DISORDER; ATTENTION DEFICIT DISORDER; CHILD; CHILDHOOD; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; DEHYDRATION; DEPRESSION; DIABETES MELLITUS; DRUG FATALITY; EXTRAPYRAMIDAL SYMPTOM; FAMILY; FAMILY HISTORY; FEMALE; HEART DISEASE; HUMAN; HYPERGLYCEMIA; INCIDENCE; INCREASED APPETITE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MANIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCHOPHARMACOLOGY; PSYCHOSIS; QT INTERVAL; REVIEW; RISK FACTOR; SEDATION; SEIZURE; SIDE EFFECT; SOCIAL ISOLATION; STEVENS JOHNSON SYNDROME; STRESS; SUDDEN DEATH; TARDIVE DYSKINESIA; UNITED STATES; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 0037622957     PISSN: 10564993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-4993(03)00006-3     Document Type: Review

References (88)

1. American Diabetes Association. Clinical practice recommendations: screening for type 2 diabetes. Diabetes Care 1998;21(Suppl 1):S11.
2. Kenny SJ, Aubert RE, Geiss LS. Prevalence and incidence of non-insulin-dependent diabetes. In: Diabetes in America. 2nd edition. Bethesda (MD): National Institutes of Health; 1995. NIH publication no. 95-1468.
3. Reynolds G, Zhi-Jun Z, Xiao-Bin Z. Association of antipsychotic drug-induced weight gain with 5-HT2C receptor gene polymorphism. Lancet 2002;359:2086-7.
4. Grey M, Boland EA, Yu C, et al. Personal and family factors associated with quality of life in adolescents with diabetes. Diabetes Care 1998;21:909-14.
5. Worrall-Davies A, Owens D, Holland P, et al. The effect of parental expressed emotion on glycemic control in children with Type 1 diabetes: parental expressed emotion and glycemic control in children. J Psychosom Res 2002;52:107-13.
6. Lo R, MacLean D. The dynamics of coping and adapting to the impact when diagnosed with diabetes. Aust J Adv Nurs 2001;19:26-32.
7. nd edition. Baltimore: Williams & Wilkins; 1996. p. 989-1005.
8. Blanz BJ, Rensch-Riemann BS, Fritz-Sigmund DI, et al. IDDM is a risk factor for adolescent psychiatric disorders. Diabetes Care 1993;16:1579-87.
9. Kovacs M, Goldston D, Obrosky DS, et al. Psychiatric disorders in youths with IDDM: rates and risk factors. Diabetes Care 1997;20:36-44.
10. Kokkonen J, Lautala P, Salmela P. The state of young adults with juvenile onset diabetes. Int J Circumpolar Health 1997;56:76-85.
11. Mayou R, Peveler R, Davies B, et al. Psychiatric morbidity in young adults with insulin-dependent diabetes mellitus. Psychol Med 1991;21:639-45.
12. Jones JM, Lawson ML, Daneman D, et al. Eating disorders in adolescent females with and without type 1 diabetes: cross sectional study. BMJ 2000;320:1563-6.
13. Murphy LM, Thompson Jr RJ, Morris MA. Adherence behavior among adolescents with type I insulin-dependent diabetes mellitus: the role of cognitive appraisal processes. J Pediatr Psychol 1997;22:811-25.
14. Tamborlane WW, Ahern J. Implications and results of the Diabetes Control and Complications Trial. Pediatr Clin North Am 1997;44:285-300.
15. Lernmark B, Persson B, Fisher L, et al. Symptoms of depression are important to psychological adaptation and metabolic control in children with diabetes mellitus. Diabet Med 1999;16:14-22.
16. McCrimmon RJ, Gold AE, Deary IJ, et al. Symptoms of hypoglycemia in children with IDDM. Diabetes Care 1995;18:858-61.
17. Sanacora G, Mason GF, Rothman DL, et al. Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 1999;56:1043-7.
18. Littorin B, Sundkvist G, Hagopian W, et al. Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment: a cohort study in young adults whose disease was initially labeled as type 2 or unclassifiable diabetes. Diabetes Care 1999;22:409-12.
19. Lebovitz HE. Rationale in the management of non-insulin-dependent diabetes. In: Leslie RD, Robbins DC, editors. Diabetes: clinical science in practice. New York: Cambridge University Press; 1995. p. 450-64.
20. Bennett PH. Epidemiology of diabetes mellitus. In: Rifkin H, Porte Jr D, editors. Ellenburg and Rifkin's Diabetes mellitus. New York: Elsevier; 1990. p. 363-77.
21. Lebovitz HE. Non-insulin-dependent (type II) diabetes mellitus. In: Kreisberg RA, editor. Diabetes mellitus. La Jolla: Publishers National Health Laboratory; 1992. p. 16-25.
22. Leslie RD, Pyke DA. Genetics of diabetes. In: Alberti KG, Krall LP, editors. The diabetes annual. Amsterdam: Elsevier; 1987. p. 39-54.
23. Dabalea D, Pettitt DJ. Intrauterine diabetic environment confers risk for type 2 diabetes mellitus and obesity in the offspring, in addition to genetic susceptibility. J Pediatr Endocrinol 2001;14:1085-91.
24. Groop L, Orho-Melander M. The dysmetabolic syndrome. J Intern Med 2001;250:105-20.
25. Scheen AJ. From obesity to diabetes: why, when and who? Acta Clin Belg 2000;55:9-15.
26. Scheen AJ. Treatment of diabetes in patients with severe obesity. Biomed Pharmacother 2000;54:74-9.
27. Foreyt JP, Poston WS. The challenge of diet, exercise and lifestyle modification in the management of the obese diabetic patient. Int J Obes Relat Metab Disord 1999;23(Suppl 7):S5-11.
28. Lean ME. Obesity: what are the current treatment options? Exp Clin Endocrinol Diabetes 1998;106(Suppl 2):22-6.
29. Campbell L, Rossner S. Management of obesity in patients with type 2 diabetes. Diabet Med 2001;18:345-54.
30. UKPDS Group. UK Prospective Diabetes Study 33: intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998;352:837-53.
31. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
32. Northam EA, Anderson PJ, Jacobs R, et al. Neuropsychological profiles of children with type 1 diabetes 6 years after disease onset. Diabetes Care 2001;24:1541-6.
33. Ryan C, Longstreet C, Morrow L. The effects of diabetes mellitus on the school attendance and school achievement of adolescents. Child Care Health Dev 1985;11:229-40.
34. McCarthy AM, Lindgren S, Mengeling MA, et al. Effects of diabetes on learning in children. Pediatrics 2002;109:E9.
35. Ryan CM. Effects of diabetes mellitus on neuropsychological functioning: a lifespan perspective. Semin Clin Neuropsychiatry 1997;2:4-14.
36. Schoenle EJ, Schoenle D, Molinari L, Largo RH. Impaired intellectual development in children with type I diabetes: association with HbA(1c), age at diagnosis and sex. Diabetologia 2002;45:108-14.
37. Austin EJ, Deary IJ. Effects of repeated hypoglycemia on cognitive function: a psychometrically validated reanalysis of the Diabetes Control Complication Trial data. Diabetes Care 1999;22:1273-7.
38. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 2000;160:3278-85.
39. Anderson RJ, Lustman PJ, Clouse RE, et al. Prevalence of depression in adults with diabetes: a systematic review. Diabetes 2000;49(Suppl 1):A64.
40. Kovacs M, Iyengar S, Goldston D, et al. Psychological functioning of children with insulin-dependent diabetes mellitus: a longitudinal study. J Pediatr Psychol 1990;15:619-32.
41. Grey M, Cameron ME, Lipman TH, et al. Psychosocial status of children with diabetes in the first 2 years after diagnosis. Diabetes Care 1995;18:1330-6.
42. Vila G, Robert JJ, Nollet-Clemencon C, et al. Eating and emotional disorders in adolescent obese girls with insulin-dependent diabetes mellitus. Eur Child Adolesc Psychiatry 1995;4:270-9.
43. Lustman PJ, Anderson RJ, Freedland KE, et al. Depression and poor glycemic control: a metaanalytic review of the literature. Diabetes Care 2000;23:934-42.
44. Grey M, Boland EA, Davidson M, et al. Coping skills training for youth with diabetes mellitus has long-lasting effects on metabolic control and quality of life. J Pediatr 2000;137:107-13.
45. Nakazato M, Kodama K, Miyamoto S, et al. Psychiatric disorders in juvenile patients with insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 2000;48:177-83.
46. Grey M, Boland EA, Davidson M, et al. Short-term effects of coping skills training as adjunct to intensive therapy in adolescents. Diabetes Care 1998;21:902-8.
47. Grey M, Lipman T, Cameron ME, et al. Coping behaviors at diagnosis and in adjustment one year later in children with diabetes. Nurs Res 1997;46:312-7.
48. Jacobson AM, Hauser ST, Willett JB, et al. Psychological adjustment to IDDM: 10-year follow-up of an onset cohort of child and adolescent patients. Diabetes Care 1997;20:811-8.
49. Goldston DB, Kelley AE, Reboussin DM, Daniel SS, Smith JA, Schwartz RP, et al. Suicidal ideation and behavior and non-compliance with the medical regimen among diabetic adolescents. J Am Acad Child Adolesc Psychiatry 1997;36:1528-36.
50. Geller B, Luby J. Child and adolescent bipolar disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 1997;36:1168-76.
51. Lewinsohn PM, Klein DN, Seely JR. Bipolar disorders in a community sample of older adolescents: prevalence, phenomenology, comorbidity, and course. J Am Acad Child Adolesc Psychiatry 1995;34:454-63.
52. Grey M, Cameron ME, Lipman TH, et al. Initial adaptation in children with newly diagnosed diabetes and healthy children. Pediatr Nurs 1994;20:17-22.
53. Stabler B, Surwit RS, Lane JD, et al. Type A behavior pattern and blood glucose control in diabetic children. Psychosom Med 1987;49:313-6.
54. Delamater AM, Kurtz SM, Bubb J, et al. Stress and coping in relation to metabolic control of adolescents with type 1 diabetes. J Dev Behav Pediatr 1987;8:136-40.
55. Niemcryk SJ, Speers MA, Travis LB, et al. Psychosocial correlates of hemoglobin Alc in young adults with type 1 diabetes. J Psychosom Res 1990;34:617-27.
56. Cohen ST, Welch G, Jacobson AM, et al. The association of lifetime psychiatric illness and increased retinopathy in patients with type I diabetes mellitus. Psychosomatics 1997;38:98-108.
57. Koenigsberg HW, Klausner E, Pelino D, et al. Expressed emotion and glucose control in insulin-dependent diabetes mellitus. Am J Psychiatry 1993;150:1114-5.
58. Takii M, Komaki G, Uchigata Y, Maeda M, Omori Y, Kubo C. Differences between bulimia nervosa and binge-eating disorder in females with type 1 diabetes: the important role of insulin omission. J Psychosom Res 1999;47:221-31.
59. Surgenor LJ, Horn J, Hudson SM. Links between psychological sense of control and disturbed eating behavior in women with diabetes mellitus: implications for predictors of metabolic control. J Psychosom Res 2002;52:121-8.
60. Crow S, Kendall D, Praus B, Thuras P. Binge eating and other psychopathology in patients with type II diabetes mellitus. Int J Eat Disord 2001;30:222-6.
61. Weglage J, Grenzebach M, Pietsch M, Feldmann R, Linnenbank R, Denecke J, et al. Behavioral and emotional problems in early-treated adolescents with phenylketonuria in comparison with diabetic patients and health controls. J Inherit Metab Dis 2000;23:487-96.
62. Keller MB, Ryan ND, Strober M, et al. Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry 2001;40:762-72.
63. Wagner KD, Rob AS, Findling R, et al. Citalopram is effective in the treatment of major depressive disorder in children and adolescents: results of a placebo controlled study. Presented at the Annual Meeting of the American College of Neuropsychopharmacology. Waikoloa, Hawaii: November 2001.
64. Emslie G, Heiligenstein JH, Wagner KD, et al. Fluoxetine for acute treatment of depression in children and adolescents: a placebo controlled randomized clinical trial. J Am Acad Child Adolesc Psychiatry 2002;41:1205-15.
65. Emslie G, Judge R. Tricyclic antidepressants and selective serotonin reuptake inhibitors: use during pregnancy, in children/adolescents and in the elderly. Acta Psychiatr Scand Suppl 2000;403:26-34.
66. Lustman PJ, Griffith LS, Clouse RE, et al. Effects of alprazolam on glucose regulation in diabetes: results of double-blind, placebo-controlled trial. Diabetes Care 1995;18:1133-9.
67. Ganzini L, Heintz RT, Hoffman WF, et al. The prevalence of tardive dyskinesia in neuroleptic-treated diabetics: a controlled study. Arch Gen Psychiatry 1991;48:259-63.
68. Kamran A, Doraiswamy PM, Jane JL, et al. Severe hyperglycemia associated with high doses of clozapine. Am J Psychiatry 1994;151:1395.
69. Newcomer JW, Haupt DW, Fucetola R, et al. Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia. Arch Gen Psychiatry 2002;59:337-45.
70. Koval MS, Rames LJ, Christie S. Diabetic ketoacidosis associated with clozapine treatment. Am J Psychiatry 1994;151:1520-1.
71. McDougle CJ, Kem DL, Posey DJ. Case series: use of ziprasidone for maladaptive symptoms in youth with autism. J Am Acad Child Adolesc Psychiatry 2002;41:921-7.
72. Centorrino F, Wurtman J, Duca K, et al. Weight-loss program for overweight subjects on atypical antipsychotics. Presented at the 155th Annual Meeting of the American Psychiatric Association. Philadelphia: May 2002.
73. Vreeland E, Menza M, Minsky S, et al. Managing antipsychotic associated weight gain: the healthy living program. Presented at the 155th Annual Meeting of the American Psychiatric Association. Philadelphia: May 2002.
74. Colon E. Psychopharmacologic management of psychiatric disorders in patients with diabetes mellitus. Semin Clin Neuropsychiatry 1997;2:66-71.
75. Van Gaal LF, Peiffer FW. The importance of obesity in diabetes and its treatment with silbutramine. Int J Obes Relat Metab Disord 2000;25(Suppl 4):S24-8.
76. Keating GM, Jarvis B. Orlistat: in the prevention and treatment of type 2 diabetes mellitus. Drugs 2001;61:2107-21.
77. Scheen AJ, Lefebvre PJ. Antiobesity pharmacotherapy in the management of type 2 diabetes. Diabetes/Metabolism Research Reviews 2000;16:114-24.
78. Leong KS, Wilding JP. Obesity and diabetes. Best Practice and Research Clinical Endocrinology and Metabolism 1999;13:221-37.
79. Hauner H. The impact of pharmacotherapy on weight management in type 2 diabetes. Int J Obes Relat Metab Disord 1999;23(Suppl 7):S12-7.
80. Jones KL, Arslanian S, Peterokova VA, Parks JS, Tomlinson MJ. Effects of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial. Diabetes Care 2002;25:89-94.
81. Delamater AM, Jacobson AM, Anderson B, et al. Psychosocial therapies in diabetes: report of the Psychosocial Therapies Working Group. Diabetes Care 2001;24:1286-92.
82. Amer KS. Children's adaptation to insulin dependent diabetes mellitus: a critical review of the literature. Pediatr Nurs 1999;25:627-41.
83. Grey M, Boland EA, Davidson M, et al. Coping skills training for youths with diabetes on intensive therapy. Appl Nurs Res 1999;12:3-12.
84. Greco P, Pendley JS, McDonell K, et al. A peer group intervention for adolescents with type 1 diabetes and their best friends. J Pediatr Psychol 2001;26:485-90.
85. Curry JF. Specific psychotherapies for childhood and adolescent depression. Biol Psychiatry 2001;49:1091-100.
86. William G. Obesity and type 2 diabetes: a conflict of interest? Int J Obes Relat Metab Disord 1999;23(Suppl 7):S2-4.
87. Greenway F. Obesity medications and the treatment of type 2 diabetes. Diabetes Technology and Therapeutics 1999;1:277-87.
88. Szydlo D. Multi-modal approach to treating obese children and children with type 2 diabetes mellitus. Presented at the 10th Annual Psychiatric Meeting. Mexico City, October 1999.